XLON:0R1F

Bristol-myers Squibb Stock Forecast

etoro logo Buy 0R1F
*Your capital is at risk
$64.90
+0.600 (+0.93%)
At Close: Aug 10, 2026

Should you buy 0R1F.L stock?

Last updated:

Based on market data through , StockInvest.us rates Bristol-Myers Squibb Co. (0R1F.L) as a Buy Candidate with a technical score of 3.06 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 7.45%
  • 3-month trend forecast Up 13.56%
  • Buy Candidate 3.06
AI Analysis AI Analysis of 0R1F.L AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add 0R1F to Watchlist?
Some Reasons Why To Add 0R1F:
  • Strong return on equity of 46.8%
  • Strong operating margin of 28.3%
  • High gross margin of 70.2%
PDF

Green day on Monday for Bristol-Myers Squibb Co. stock after gaining 0.93%
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jul 21, 2026 Gain 7.45%

The Bristol-Myers Squibb Co. stock price gained 0.93% on the last trading day (Monday, 10th Aug 2026), rising from $64.30 to $64.90. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.27% from a day low at $63.97 to a day high of $65.42. The price has risen in 8 of the last 10 days and is up by 4.51% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 7 thousand more shares were traded than the day before. In total, 14 thousand shares were bought and sold for approximately $884.13 thousand.

The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $66.04 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 13.56% during the next 3 months and, with a 90% probability hold a price between $65.73 and $75.00 at the end of this 3-month period.

0R1F.L Signals & Forecast

The Bristol-Myers Squibb Co. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $64.49 and $60.06. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Bristol-Myers Squibb Co. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, August 04, 2026, and so far it has fallen -0.99%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Bristol-Myers Squibb Co. stock

Bristol-Myers Squibb Co. finds support from accumulated volume at $64.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.45 between high and low, or 2.27%. For the last week, the stock has had daily average volatility of 4.17%.

Our recommended stop-loss: $62.41 (-3.84%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (0R1F.L) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Bristol-Myers Squibb Co. to open at $64.76, and during the day (based on 14 day Average True Range), to move between $63.56 and $66.24, which gives a possible trading interval of +/-$2.69 (+/-4.23%) up or down from last closing price. If Bristol-Myers Squibb Co. takes out the full calculated possible swing range there will be an estimated 4.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $64.60 (0.46%) than the resistance at $65.55 (1.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Bristol-Myers Squibb Co. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Bristol-Myers Squibb Co. stock to perform well in the short-term.

Current score: 3.055 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $64.76 ( 0.211%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

0R1F.L Performance

Trading levels for 0R1F.L

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 66.21 2.02%
R2 65.66 1.17%
R1 65.32 0.643%
Price 64.90
S1 64.21 -1.06%
S2 63.87 -1.59%
S3 63.31 -2.44%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 65.55 1.00%
Price 64.90
S1 64.60 -0.462%
S2 57.25 -11.79%
S3 55.85 -13.94%

0R1F Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 02, 2026 Jul 02, 2026 Jul 02, 2026 $0.630 1.12%
2 Apr 02, 2026 Apr 02, 2026 Apr 02, 2026 $0.630 1.03%
3 Jan 02, 2026 Jan 02, 2026 Jan 02, 2026 $0.630 0%
4 Oct 03, 2025 Oct 03, 2025 Oct 03, 2025 $0.620 0%
5 Jul 03, 2025 Jul 03, 2025 Jul 03, 2025 $0.620 0%

FAQ

What is the symbol for Bristol-Myers Squibb Co. Stock and on which exchange is it traded?
The symbol for Bristol-Myers Squibb Co. is 0R1F.L and it is traded on the XLON (London Stock Exchange).

Should I buy or sell Bristol-Myers Squibb Co. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Bristol-Myers Squibb Co. (0R1F.L) as a Buy Candidate with a technical score of 3.06 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Buy signal began on Jul 21, 2026, the price has risen 7.45%. The current 3-month trend forecast projects a rise of 13.56%.

How to buy Bristol-Myers Squibb Co. Stock?
Bristol-Myers Squibb Co. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bristol-Myers Squibb Co. Stock.

What's the current price of Bristol-Myers Squibb Co. Stock?
As of the end of day on the Aug 10, 2026, the price of an Bristol-Myers Squibb Co. (0R1F.L) share was $64.90.

What is the 52-week high and low for Bristol-Myers Squibb Co. Stock?
The 52-week high for Bristol-Myers Squibb Co. Stock is $71.07 and the 52-week low is $52.93.

What is the market capitalization of Bristol-Myers Squibb Co. Stock?
As of the Aug 10, 2026, the market capitalization of Bristol-Myers Squibb Co. is 105.93B.

When is the next earnings date for Bristol-Myers Squibb Co.?
The upcoming earnings date for Bristol-Myers Squibb Co. is Oct 29, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE